Susquehanna International Group, LLP Teva Pharmaceutical Industries LTD Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $2.44 Million - $2.93 Million	154,300 Added 11.16%	1,536,400 $27.7 Million
Q2 2024 Aug 15, 2024	SELL	$12.78 - $17.4 $23.6 Million - $32.2 Million	-1,848,500 Reduced 57.22%	1,382,100 $22.5 Million
Q1 2024 May 07, 2024	BUY	$10.67 - $14.43 $7.51 Million - $10.2 Million	703,400 Added 27.83%	3,230,600 $45.6 Million
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $7.23 Million - $9.47 Million	-890,900 Reduced 26.06%	2,527,200 $26.4 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $11 Million - $15.7 Million	-1,464,000 Reduced 29.99%	3,418,100 $34.9 Million
Q2 2023 Aug 11, 2023	BUY	$7.2 - $9.47 $1.67 Million - $2.2 Million	232,300 Added 5.0%	4,882,100 $36.8 Million
Q1 2023 May 16, 2023	SELL	$8.36 - $11.37 $6.23 Million - $8.47 Million	-745,100 Reduced 13.81%	4,649,800 $41.2 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $243,270 - $290,088	30,600 Added 0.57%	5,394,900 $49.2 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $2.03 Million - $3.54 Million	-296,600 Reduced 5.24%	5,364,300 $43.3 Million

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.